[
  {
    "date": "2023-12-30",
    "symbol": "IFRX",
    "period": "FY",
    "revenue": 63089,
    "costofsales": 532262,
    "grossprofit": -469173,
    "salesandmarketingexpense": 4001299,
    "researchanddevelopmentexpense": 41024131,
    "generalandadministrativeexpense": 12628756,
    "otherincome": 13219704,
    "otherexpensebyfunction": 4440,
    "profitlossfromoperatingactivities": -44908096,
    "financeincome": 3804827,
    "financecosts": 35628,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": -1841872,
    "otherfinanceincomecost": 313240,
    "profitloss": -42667529,
    "othercomprehensiveincomenetoftaxexchangedifferencesontranslationotherthantranslationofforeignoperations": 125085,
    "comprehensiveincome": -42542444,
    "weightedaverageshares": 54940137,
    "basicearningslosspershare": -0.78,
    "dilutedearningslosspershare": -0.78,
    "propertyplantandequipment": 289577,
    "rightofuseassets": 1071666,
    "intangibleassetsandgoodwill": 68818,
    "othernoncurrentassets": 257267,
    "noncurrentfinancialassets": 9052741,
    "noncurrentassets": 10740069,
    "inventories": 11367807,
    "othercurrentassets": 4036650,
    "currenttaxassetscurrent": 3791564,
    "otherfinancialassets": 77504518,
    "cashandcashequivalents": 12767943,
    "currentassets": 109468483,
    "assets": 120208552,
    "issuedcapital": 7065993,
    "sharepremium": 334211338,
    "otherreserves": 40050053,
    "retainedearnings": -286127819,
    "equityattributabletoownersofparent": 7382166,
    "equity": 102581730,
    "noncurrentleaseliabilities": 745716,
    "othernoncurrentliabilities": 36877,
    "noncurrentliabilities": 782593,
    "tradeandothercurrentpayables": 11974362,
    "currentgovernmentgrants": 33300000,
    "currentleaseliabilities": 374329,
    "currentprovisionsforemployeebenefits": 1609766,
    "othercurrentliabilities": 2885772,
    "currentliabilities": 16844229,
    "liabilities": 17626822,
    "equityandliabilities": 120208552,
    "numberofsharesoutstanding": 58883272,
    "gainslossesonexchangedifferencesontranslationnetoftax": 125085,
    "issueofequity": 1687110,
    "issuanceofcommonshare": 14059252,
    "shareissuerelatedcost": 3360626,
    "increasedecreasethroughsharebasedpaymenttransactions": 3414489,
    "increasedecreaseinnumberofordinarysharesissued": 3235723,
    "increasedecreasethroughexerciseofoptions": 14431,
    "increasedecreasethroughexerciseofoptionsshares": 120257,
    "adjustmentsfordepreciationexpense": 567780,
    "adjustmentsforfinanceincomecost": 2240566,
    "adjustmentsforsharebasedpayments": 3414489,
    "adjustmentsforunrealisedforeignexchangelossesgains": 413017,
    "adjustmentsforincreasedecreaseinfinancialassetsfromgovernmentgrantsindollars": 732971,
    "adjustmentsfordecreaseincreaseinothercurrentassets": 7825182,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 297518,
    "adjustmentsforincreasedecreaseinotherliabilities": 2738164,
    "adjustmentsforincreasedecreaseinliabilitiesfromgovernmentgrantreceived": -6209266,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 6986824,
    "adjustmentsfordecreaseincreaseininventories": -11367807,
    "interestreceivedclassifiedasoperatingactivities": 1732284,
    "interestpaidclassifiedasoperatingactivities": 36025,
    "cashflowsfromusedinoperatingactivities": -37812966,
    "purchaseofpropertyplantandequipmentintangibleassetsotherthangoodwillinvestmentpropertyandothernoncurrentassets": 81100,
    "purchaseofcurrentandnoncurrentfinancialassets": 104051972,
    "proceedsfromdisposalormaturityofavailableforsalefinancialassets": 86436456,
    "cashflowsfromusedininvestingactivities": -17696616,
    "proceedsfromissuingshares": 56483929,
    "transactioncostsfromissuanceofcommonshares": 3360626,
    "proceedsfromexerciseofoptions": 236943,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 373977,
    "cashflowsfromusedinfinancingactivities": 52986269,
    "increasedecreaseincashandcashequivalents": -2523313,
    "effectofexchangeratechangesoncashandcashequivalents": -974099,
    "disclosureofsummaryofmaterialaccountingpoliciesexplanatorypolicytextblock": "2.Summary of material accounting policies",
    "disclosureofnewandamendedstandardsadoptedbythegroupexplanatorypolicytextblock": "(a)New and amended standards adopted by the Group",
    "descriptionofaccountingpolicynewstandardsnotyetadoptedexplanatorypolicytextblock": "(b)New standard not yet adopted",
    "descriptionofaccountingpolicycurrentandnoncurrentclassificationexplanatorypolicytextblock": "(c)Current and non-current classification",
    "descriptionofaccountingpolicyforgrantsfromgovernmentpoilcytextblock": "(e)Grants from government and similar bodies",
    "notestothecashflowstatementpolicytextblock": "(f)Notes to the cash flow statement, cash, and cash equivalents",
    "disclosureofsignificantaccountingjudgementsestimatesandassumptionspolicytextblock": "3. Significant accounting judgements, estimates and assumptions",
    "disclosureofsharecapitalconsistingsolelyofordinarysharesexplanatory": "Unless otherwise stated, such subsidiaries have share capital consistingsolely of ordinary shares that are held directly by the Company, and the proportion of ownership interests held equals the voting rightsheld by the Company.",
    "disclosureofsalesandmarketingexpensetextblock": "Sales and marketing expenses",
    "disclosureofotherincomeexplanatorytextblock": "Other income decreased in 2023, compared to the prior year, due to the incurrence of less expenses eligible forreimbursement under the grant and the end of the grant period on June 30, 2023.",
    "disclosureofnetfinancialresulttextblock": "Net financial result",
    "disclosurecashcashequivalentsandfinancialassetstextblock": "In 2023, if the Euro had weakened/strengthenedby 10% against the U.S. dollar with all other variables held constant, the Group’s loss would have been €1 million higher/€1million lower, mainly as a result of foreign exchange on translation of U.S. dollar-denominated assets of InflaRx N.V. and InflaRx GmbH.",
    "disclosureofcompensationofthegroupsexecutivemanagementexplanatory": "Compensation of the Group’s executivemanagement for the 12 months ending December 31, 2023:",
    "countryofincorporation": "Jena and Munich, Germany",
    "descriptionoffunctionalcurrency": "EUR",
    "proportionofownershipinterestinsubsidiary": 1,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Operating subsidiary, R&D, holder of all IP",
    "revenuefromgovernmentgrants": 13155250,
    "liabilityforfuturepolicybenefitperiodexpense": 64454,
    "otherfinanceincome": 13219704,
    "employeebenefitsexpense": 93482,
    "revenuefrominterest": 3804827,
    "interestexpense": 16538,
    "interestexpenseonleaseliabilities": 19090,
    "financeincomecost": 3769199,
    "foreignexchangeincome": 5529389,
    "foreignexchangeexpense": 7371261,
    "foreignexchangeresult": -1841872,
    "otherfinancialresult": 313240,
    "netfinancialresult": 2240566,
    "numberofoutstandingshareoptions": 148433,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 148433,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstanding": 888632,
    "numberofweightedaveragesharesoutstanding": 1.86,
    "numberofsharesoptionsexercisable": 888632,
    "waepexercisables": 1.86,
    "numberofoutstandingsharesoption": 6584946,
    "numberofoutstandingsweightedaverageearningpershare": 2.12,
    "numberofshareoptiongrantedinsharebasedpaymentarrangement": 1735750,
    "numberofweightedaverageearningpersharegrantedinsharebasedpaymentarrangement": 2.58,
    "numberofshareoptionexercisedinsharebasedpaymentarrangement": -31000,
    "numberofweightedaverageearningpershareexercisedinsharebasedpaymentarrangement": 2.7,
    "numberofshareoptionforfeitedinsharebasedpaymentarrangement": -105327,
    "numberofweightedaverageearningpershareforfeitedinsharebasedpaymentarrangement": 2.16,
    "numberofotherequityinstrumentexercisableinsharebasedpaymentsarrangement": 5577384,
    "numberofweightedaverageearningpershareexercisableinsharebasedpaymentsarrangement": 2.01,
    "shareoptionsgrantedoptions": 1454250,
    "fairvalueperoptions": 2.11,
    "foreignexchangerateasofgrantdate": 0.9008,
    "fairvaluesperoptions": 1.9,
    "sharepriceatgrantdateexerciseprices": 2.37,
    "descriptionofexpectedvolatilityshareoptionsgranted": 1.35,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": "P7Y11M8D",
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.03571,
    "propertyplantandequipmentcarryingamountatcostofrevaluedassets01": 1491525,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 55123,
    "disposalsandretirementpropertyplantandequipment": -2595,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -14342,
    "operatingleasesincomestatementdepreciationexpensesonpropertysubjecttoorheldforlease": 93791,
    "netbookvaluepropertyandequipment": 289577,
    "rightofuseassetsrevaluationsurplus01": 2661118,
    "depreciationexpense": 353398,
    "additionstorightofuseassets": 91125,
    "increasedecreasethroughnetexchangedifferenceotherprovisions": -9349,
    "netbookvalueofrightofuseasset": 1028098,
    "intangibleassets": -716130,
    "amortisationintangibleassetsotherthangoodwill": 96063,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 25977,
    "disposalsandretirementintangibleassetsotherthangoodwill": 7009,
    "increasedecreasethroughnetexchangedifferenceintangibleassetotherthangoodwill": -111,
    "netbookvalueintangibleasset": 42841,
    "leaseliabilities": 1120048,
    "additionalprovisionsotherprovisions": 140128,
    "decreasethroughderecognitionfinancialassets": 20555,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 353422,
    "deferredtaxexpenseincomerecognisedinprofitorloss": -396,
    "gainslossesonexchangedifferenceontranslationnetoftax": -2391,
    "depreciationamortisationandimpairmentlossreversalofimpairmentlossrecognisedinprofitorloss": 377925,
    "interestexpenseonbonds": 19090,
    "rentalexpense": 6261,
    "expenserelatingtovariableleasepaymentsnotincludedinmeasurementofleaseliabilities": 6261,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": 403276,
    "currentrawmaterialsandcurrentproductionsupplies": 423560,
    "unfinishedgoods": 10614159,
    "finishedgoods": 330087,
    "inventoriestotal": 11367807,
    "prepaidexpense": 257267,
    "noncurrentotherassets": 257267,
    "prepayments": 3670167,
    "currentprepaidexpenses": 272999,
    "otheradjustmentstoreconcileprofitloss": 4036648,
    "totalotherasset": 4293915,
    "profitlossbeforetax": -42667529,
    "taxrate": 0.286,
    "taxbenefitsattaxrate": 12160545,
    "taxlossesforwhichnodeferredtaxassetwasrecognizedone": -12127977,
    "nonrecognitionoftaxeffectonsharebasedpayment": -32182,
    "nondeductibleexpensesfortaxpurposesindollars": -46907,
    "otherdifferencesduetotaxrateindollars": 46521,
    "othernoncurrentfinancialassets": 9052741,
    "othercurrentfinancialassets": 77504518,
    "tradeandotherpayables": 14716441,
    "shorttermdepositsclassifiedascashequivalents": 4120951,
    "cash": 5041802,
    "othercashandcashequivalents": 12767942,
    "currentaccruedexpensesandothercurrentliabilities": 4414143,
    "accruedliabilitiesfromcommercialactivities": 1400382,
    "tradeandotherpayablestotradesuppliers": 5102700,
    "otherpayables": 3942909,
    "tradeandotherpayablesundiscountedcashflows": 14860134,
    "descriptionofexposuretorisk": "Future development costs; Recognized financial assets and liabilities not denominated in Euro",
    "descriptionofreasonsforfairvaluemeasurementassets": "Forecasted cash flows Sensitivity analysis",
    "descriptionofhowentityreflectsitsriskmanagementstrategybyusinghedgeaccountinganddesignatinghedgingrelationshipsthatitfrequentlyresets": "Achievement of a natural hedge in the future",
    "currentandnoncurrentfinancialassetssecuritiesandaccruedinterest": 80935197,
    "cashandcashequivalentsifdifferentfromstatementoffinancialposition": 8051366,
    "financialassetsheldformanagingliquidityrisk": 88986563,
    "sensitivityanalysisconversionrate": 1.2155,
    "sensitivityanalysiscarryingamount": 98873959,
    "balanceswithbanks": 7626992,
    "debtsecurities": 85727461,
    "noncurrentportionofothernoncurrentborrowings": 237621,
    "othercurrentborrowingsandcurrentportionofothernoncurrentborrowings": 701407,
    "totalfundsavailable": 99434432,
    "grossleaseliabilities": 391158,
    "effectofdiscounting": 16829,
    "netdeferredtaxliabilities": 374329,
    "totalleases": 397942,
    "expenserelatingtoleasesoflowvalueassetforwhichrecognitionexemptionhasbeenused": 4816,
    "leasecommitmentsforshorttermleasesforwhichrecognitionexemptionhasbeenused": 1968,
    "capitalizedleases": 391158,
    "othershorttermemployeebenefits": 2783675,
    "paymentofleaseliabilitiesclassifiedasfinancingactivities": 2507453,
    "currentfinancialassetsatamortisedcost": 5291128,
    "totalcompensation": 5882288,
    "rentalcontractsfixedperiod": "P1Y",
    "amortizedperiod": "P3Y",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P3Y",
    "annualizedaveragesharepriceperiod": "P5Y",
    "accruedincomeincludingcontractassets": 4400000,
    "otherassets": 3700000,
    "inventorywritedown2011": 521000,
    "sellingexpense": 1000000,
    "otherfinancecost": 1900000,
    "netfinancialcost": 500000,
    "interestincomeondeposits": 3200000,
    "shorttermmarketablesecurities": 3800000,
    "taxeffectofforeigntaxrates": 4300000,
    "foreignexchangeloss": 1800000,
    "increasedecreaseinallowanceaccountforcreditlossesoffinancialassets": 300000,
    "weightednumberofcommonsharesoutstanding": 54940137,
    "losspershare": 0.78,
    "exercisepriceofoutstandingshareoptions": 0.01,
    "conversionrate": 0.905,
    "averagerate": 0.9246,
    "maximumnumberofcommonsharesavailableforgrant": 2341097,
    "ordinarysharespercentage": 0.04,
    "weightedaveragefairvalueoptionsgrantedduringtheyear": 2.58,
    "exercisepricerange": 1.86,
    "optionsgranted": 1735750,
    "numberofstockoptionsforfeited": 31000,
    "numberofoptionsexercised": 105327,
    "researchanddevelopmentexpenses": 858,
    "sellinggeneralandadministrativeexpense": 95205,
    "cashoutflowforleases": 0.4,
    "writedownsreversalsofinventories": 500000,
    "corporateincometax": 0.15,
    "solidaritysurcharge": 0.008,
    "tradetaxes": 0.13065,
    "totaltaxrate": 0.2574,
    "effectiveincometaxratereconciliationsatfederalstatutoryincometaxratepercent": 0.21,
    "effectiveincometaxratereconciliationtaxsettlementsstateandlocalpercent": 0.0474,
    "gainslossesonchangeinvalueofforwardelementsofforwardcontractsnetoftax": 243800000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 196000000,
    "taxbasisofinvestmentcostforincometaxpurposes": 164000000,
    "taxlosscarryforwards": 14300000,
    "taxableincome": 0.8,
    "currentinterestreceivable": 1390280,
    "currentandnoncurrentfinancialassets": 85.5,
    "fixedinterest": 0.003,
    "capitalordinarysharesissued": 58883272,
    "parvaluepershare": 0.12,
    "commonshares": 50000000,
    "netproceeds": 14400000,
    "proceedsofferingcost": 2500000,
    "underwritingdiscounts": 39100000,
    "otherexpensebynature": 400000,
    "proceedsfromofferingcost": 38700000,
    "dividendspaidordinaryshares": 2500000,
    "dividendspaidordinarysharespershare": 5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofadditionalshareauthorized": 500000,
    "aggregatepurchaseprice": 7500000,
    "aggregateinitialoffering": 250000000,
    "nominalvalue": 0.12,
    "ordinarysharesvalue": 98754,
    "ordinarysharesoldprice": 1.85,
    "numberofsharesissued": 21503,
    "soldatprice": 3.35,
    "ordinarysharepurchase": 110000000,
    "preferredunitissued": 110000000,
    "nominalorprincipalamountoffinancialinstrumentondiscontinuationofmeasurementatfairvaluethroughprofitorlossbecausecreditderivativeisusedtomanagecreditrisk": 0.12,
    "companyissuedcapital": 1,
    "expectedreimbursementotherprovisions": 70000,
    "commonsharesinexcessofnominalvalue": 0.12,
    "paymentsforaccruedpayments": 2700000,
    "variablesheldconstant": 0.1,
    "gainslossesonexchangedifferencesontranslationbeforetax": 1000000,
    "exchangeratefluctuations": 0.9945,
    "maximumexposuretocreditrisk": 99300000,
    "noncurrentrestrictedcashandcashequivalents": 12800000,
    "financialassets": 86600000,
    "cashonhand": 8800000,
    "exchangerate": 1,
    "interestincomeonimpairedfinancialassetsaccrued": 800000,
    "entityregistrantname": "InflaRx N.V.",
    "tradingsymbol": "IFRX",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--12-31",
    "entitycommonstocksharesoutstanding": 58883272,
    "amendmentflag": "false",
    "entitycentralindexkey": 1708688,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-38283",
    "entityincorporationstatecountrycode": "P7",
    "entityaddressaddressline1": "Winzerlaer Str. 2",
    "entityaddressaddressline2": 7745,
    "entityaddresscityortown": "Jena",
    "entityaddresscountry": "DE",
    "contactpersonnelname": "Dr. Thomas Taapken",
    "cityareacode": 49,
    "localphonenumber": "(3641) 508 180",
    "security12btitle": "Ordinary Shares, nominal value €0.12 per share",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 1251,
    "auditorname": "EY GmbH & Co. KG Wirtschaftsprüfungsgesellschaft",
    "auditorlocation": "Munich, Germany"
  },
  {
    "date": "2022-12-31",
    "symbol": "IFRX",
    "period": "FY",
    "researchanddevelopmentexpense": 37526090,
    "sellinggeneralandadministrativeexpense": 1533469,
    "operatingexpense": 52395654,
    "otherincome": 20100000,
    "otherexpensebynature": 1381,
    "operatingresult": -32237866,
    "financeincome": 608679,
    "financecosts": 45250,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 2442297,
    "otherfinanceincomecost": -252471,
    "profitloss": -29484611,
    "lossfortheperiod": -29484611,
    "impairmentlossimpairmentgainandreversalofimpairmentlossdeterminedinaccordancewithifrs9": -4206810,
    "comprehensiveincome": 4206810,
    "weightedaverageshares": 44207873,
    "basicearningslosspershare": -0.67,
    "dilutedearningslosspershare": -0.67,
    "propertyplantandequipment": 328920,
    "rightofuseassets": 1311809,
    "intangibleassetsotherthangoodwill": 138905,
    "assetsother": 308066,
    "financialassets": 2900902,
    "noncurrentassets": 4988602,
    "othercurrentassets": 14170510,
    "currenttaxassetscurrent": 1432087,
    "derivativefinancialassetsheldfortrading": 732971,
    "othercurrentfinancialassets": 64810135,
    "cashandcashequivalents": 16265355,
    "currentassets": 97411058,
    "assets": 102399660,
    "issuedcapital": 5364452,
    "sharepremium": 282552633,
    "otherreserves": 36635564,
    "retainedearnings": -243460290,
    "equityattributabletoownersofparent": 7257081,
    "equity": 7257080,
    "noncurrentleaseliabilities": 987307,
    "otherliabilitie": 36877,
    "noncurrentliabilities": 1024184,
    "tradeandothercurrentpayables": 4987538,
    "liabilitiesfromgovernmentgrantsreceived": 6209266,
    "currentleaseliabilities": 369376,
    "currentprovisionsforemployeebenefits": 1312248,
    "othercurrentliabilities": 147608,
    "currentliabilities": 13026036,
    "liabilities": 14050220,
    "equityandliabilities": 102399660,
    "numberofsharesoutstanding": 44703763,
    "gainslossesonexchangedifferencesontranslationnetoftax": 4206810,
    "issuanceofcommonshares": 2349624,
    "issuanceofcommonshare": 500000,
    "shareissuerelatedcost": 47735,
    "increasedecreasethroughsharebasedpaymenttransactions": 6044356,
    "adjustmentsfordepreciationexpense": 596597,
    "adjustmentsforfinanceincomecost": 2753255,
    "adjustmentsforsharebasedpayments": 6044356,
    "adjustmentsforunrealisedforeignexchangelossesgains": 385359,
    "adjustmentsforincreasedecreaseinfinancialassetsfromgovernmentgrantsindollars": -732971,
    "adjustmentsfordecreaseincreaseinothercurrentassets": -3308485,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": -64024,
    "adjustmentsforincreasedecreaseinotherliabilities": 9403,
    "adjustmentsforincreasedecreaseinliabilitiesfromgovernmentgrantreceived": -2090734,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -3586706,
    "interestreceivedclassifiedasoperatingactivities": 1287200,
    "interestpaidclassifiedasoperatingactivities": 44946,
    "cashflowsfromusedinoperatingactivities": -33742817,
    "purchaseofpropertyplantandequipmentintangibleassetsotherthangoodwillinvestmentpropertyandothernoncurrentassets": 162391,
    "purchaseofcurrentandnoncurrentfinancialassets": 64474543,
    "proceedsfromdisposalormaturityofavailableforsalefinancialassets": 83995029,
    "cashflowsfromusedininvestingactivities": 19358095,
    "proceedsfromissuingshares": 2349624,
    "transactioncostsfromissuanceofcommonshares": 47735,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 364430,
    "cashflowsfromusedinfinancingactivities": 1937459,
    "increasedecreaseincashandcashequivalents": -12447262,
    "effectofexchangeratechangesoncashandcashequivalents": 2462622,
    "disclosureofcorporateinformationtextblock": " 1. Corporate information ",
    "disclosureofconsolidatedstatementsofoperationsandcomprehensivelossexplanatory": " 3. Consolidated statements of operations and comprehensive loss ",
    "disclosureofbasisofpreparationoffinancialstatementsexplanatorypolicytextblock": "Basis of preparation",
    "descriptionofaccountingpolicynewstandardsnotyetadoptedexplanatorypolicytextblock": "New standard not yet adopted",
    "descriptionofaccountingpolicycurrentandnoncurrentclassificationexplanatorypolicytextblock": "Current and non-current classification",
    "descriptionofaccountingpolicyforgrantsfromgovernmentpoilcytextblock": "Grants from government and similar bodies",
    "notestothecashflowstatementpolicytextblock": "Notes to the cash flow statement, cash, and cash equivalents",
    "disclosureofsignificantaccountingjudgementsestimatesandassumptionspolicytextblock": "Significant accounting judgements, estimates and assumptions",
    "scheduleofotherincometabletextblock": "      Other income     2022      2021      2020             (in €)       Other income from government grants      20,116,542       —       —       Further other income      42,627       54,221       221,748       Total      20,159,169       54,221       221,748    ",
    "disclosureofemployeebenefitsexpenses": "      Employee benefits expenses     2022      2021      2020                    (in €)              Wages and salaries      6,863,423       6,919,166       6,270,757       Social security contributions (employer’s share)      672,534       671,697       551,804       Equity-settled share-based payment expenses (see Note 4.7)      6,044,356       4,332,205       1,116,791       Other      503,351       519,425       421,887       Total      14,083,664       12,442,493       8,361,239    ",
    "disclosureoffinanceresult": "      Finance Result     2022      2021      2020                    (in €)              Finance income                           Interest income      608,679       109,391       887,702       Finance expenses                              Interest expenses      (23,303)      (10,714)      (18,689)      Interest on lease liabilities      (21,947)      (14,055)      (7,311)      Total      563,429       84,622       861,702    ",
    "dislcosureofforeignexchangeresult": "      Foreign exchange result     2022      2021      2020                    (in €)              Foreign exchange result                           Foreign exchange income      6,924,697       5,569,836       3,656,922       Foreign exchange expense      (4,482,399)      (3,605,701)      (4,433,435)      Total      2,442,298       1,964,135       (776,513)   ",
    "disclosureofotherfinancialresult": "            2022      2021      2020                    (in €)              Other financial result      (252,471)      (44,000)      (126,000)   ",
    "disclosureofsharebasedpayments": "            2022 Options       2022 WAEP*       2021 Options       2021 WAEP        Outstanding at January 1      148,433      €0.01       148,433      €0.01       Exercised during the year      —       —       —       —       Outstanding at December 31      148,433      €0.01       148,433      €0.01       Exercisable at December 31      148,433      €0.01       148,433      €0.01  ",
    "countryofincorporation": "United States",
    "descriptionoffunctionalcurrency": "USD",
    "proportionofownershipinterestinsubsidiary": 1,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Subsidiary for basic research",
    "researchanddevelopmentsexpense": 37526090,
    "employeebenefitsexpense": 2552071,
    "revenuefrominterest": 608679,
    "interestexpense": 23303,
    "interestexpenseonleaseliabilities": 21947,
    "totalfinanceresult": 563429,
    "numberofoutstandingshareoptions": 0.01,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 0.01,
    "numberofoutstandingsharesoption": 1.84,
    "numberofshareoptiongrantedinsharebasedpaymentarrangement": 1.88,
    "numberofshareoptionexercisedinsharebasedpaymentarrangement": 2.11,
    "numberofshareoptionforfeitedinsharebasedpaymentarrangement": 1.76,
    "numberofotherequityinstrumentexercisableinsharebasedpaymentsarrangement": 1.81,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 1966666,
    "fairvalueperoptions": 2.04,
    "foreignexchangerateasofgrantdate": 0.976,
    "fairvaluesperoptions": 1.99,
    "sharepriceatgrantdateexerciseprices": 2.44,
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.013500000000000002,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": 4,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 4.15,
    "propertyplantandequipmentcarryingamountatcostofrevaluedassets01": -1124419,
    "operatingleasesincomestatementdepreciationexpensesonpropertysubjecttoorheldforlease": 113894,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 160491,
    "increasedecreasethroughnetexchangedifferencespropertyplantandequipment": -17286,
    "netbookvaluepropertyandequipment": 328920,
    "rightofuseassetsrevaluationsurplus01": -1392664,
    "depreciationexpense": 384432,
    "additionstorightofuseassets": 281429,
    "increasedecreasethroughnetexchangedifferenceotherprovisions": -6911,
    "netbookvalueofrightofuseasset": 1311809,
    "intangibleassets": 584345,
    "amortisationintangibleassetsotherthangoodwill": 98271,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 1900,
    "increasedecreasethroughnetexchangedifferenceintangibleassetotherthangoodwill": -348,
    "netbookvalueintangibleasset": 138905,
    "leaseliabilities": 1356684,
    "additionalprovisionsotherprovisions": 281429,
    "decreasethroughderecognitionfinancialassets": 20555,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 343874,
    "deferredtaxexpenseincomerecognisedinprofitorloss": 304,
    "gainslossesonexchangedifferenceontranslationnetoftax": 6854,
    "depreciationamortisationandimpairmentlossreversalofimpairmentlossrecognisedinprofitorloss": 384432,
    "interestexpenseonbonds": 21947,
    "rentalexpense": 6261,
    "expenserelatingtovariableleasepaymentsnotincludedinmeasurementofleaseliabilities": 6261,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorloss": 412640,
    "prepaidexpense": 308066,
    "noncurrentotherassets": 308066,
    "prepayments": 9776505,
    "currentprepaidexpenses": 1841935,
    "otheradjustmentstoreconcileprofitloss": 14170511,
    "totalotherasset": 14478577,
    "profitlossbeforetax": -29484611,
    "applicabletaxrate": 0.292,
    "taxexpenseincomeatapplicabletaxrate": 8610381,
    "taxlossesforwhichnodeferredtaxassetwasrecognizedone": -7480169,
    "nonrecognitionoftaxeffectonsharebasedpayment": -1251830,
    "nondeductibleexpensesfortaxpurposesindollars": -22067,
    "otherdifferencesduetotaxrateindollars": 143686,
    "othernoncurrentfinancialassets": 2900902,
    "financialassetsfromgovernmentgrantsindollars": 732971,
    "currentfinancialassets": 64791088,
    "liabilitiesfromgovernmentgrantsindollars": 6209266,
    "tradeandotherpayables": 4987538,
    "shorttermdepositsclassifiedascashequivalents": 3422,
    "cash": 16261932,
    "othercashandcashequivalents": 16265354,
    "currentaccruedexpensesandothercurrentliabilities": 2254550,
    "tradeandotherpayablestotradesuppliers": 1566400,
    "otherpayables": 1166588,
    "tradeandotherpayablesundiscountedcashflows": 4987538,
    "currentprepaymentsandothercurrentassets": 7376866,
    "cashandcashequivalentsrecognisedasofacquisitiondate": 4356512,
    "totalassetsexposedtotherisk": 11733378,
    "closingforeignexchangerate": 0.9599,
    "profitlossattributabletoownersofparent": 1303709,
    "carryingamount": 13037087,
    "shorttermdepositsnotclassifiedascashequivalents": 3422,
    "balanceswithbanks": 16261932,
    "marketablesecuritiescurrentandnoncurrent": -67175879,
    "othernoncurrentportion": 237296,
    "othercurrent": 278815,
    "investmentfundsamountcontributedtofairvalueofplanassets": 83957344,
    "grossleaseliabilities": 1380000,
    "effectofdiscounting": 23317,
    "netdeferredtaxliabilities": 1356683,
    "totalleases": 1391223,
    "expenserelatingtoleasesoflowvalueassetforwhichrecognitionexemptionhasbeenused": 11223,
    "capitalizedleases": 1380000,
    "othershorttermemployeebenefits": 248725,
    "paymentofleaseliabilitiesclassifiedasfinancingactivities": 529859,
    "currentfinancialassetsatamortisedcost": 778584,
    "totalcompensation": 8361163,
    "grantfunding": 25600000,
    "dividendsreceived": 17300000,
    "rentalcontractsfixedperiod": "three years",
    "amortizedperiod": "three years",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "five years",
    "accruedincomeincludingcontractassets": 2300000,
    "otherasset": 10600000,
    "employeerelatedcosts": 1000000,
    "effectiveincometaxratereconciliationsnondeductibleexpensesharebasedpaymentarrangementamount": 900000,
    "increaseinotherexpenses": 1200000,
    "interestincomeondeposits": 500000,
    "increasedecreaseinallowanceaccountforcreditlossesoffinancialassets": 252471,
    "weightednumberofcommonsharesoutstanding": 44207873,
    "exercisepriceofoutstandingshareoptions": 0.01,
    "conversionrate": 0.9376,
    "averagerate": 0.9489,
    "unexercisedoptionpershare": 1.86,
    "maximumnumberofcommonsharesavailableforgrant": 2341097,
    "ordinarysharespercentage": 0.04,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions": 6.7,
    "weightedaveragefairvalueeoptionsgrantedduringtheyearusd": 1.7,
    "exercisepricerange": 5.14,
    "optionsgranted": 1223500,
    "numberofstockoptionsforfeited": 136259,
    "numberofoptionsexercised": 14930,
    "capitalavailableissuance": 0.03,
    "researchanddevelopmentexpenses": 858,
    "generalandadministrativeexpense": 97413,
    "cashoutflowforleases": 391743,
    "corporateincometax": 0.15,
    "solidaritysurcharge": 0.008,
    "tradetaxes": 0.13699999999999998,
    "averageeffectivetaxrate": 0.295,
    "totaltaxrate": 0.25739999999999996,
    "effectiveincometaxratereconciliationsatfederalstatutoryincometaxratepercent": 0.21,
    "effectiveincometaxratereconciliationtaxsettlementsstateandlocalpercent": 0.047400000000000005,
    "gainslossesonchangeinvalueofforwardelementsofforwardcontractsnetoftax": 211300000,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 163400000,
    "taxbasisofinvestmentcostforincometaxpurposes": 131600000,
    "taxlosscarryforwards": 14100000,
    "taxableincome": 0.8,
    "currentinterestreceivable": 791344,
    "currentandnoncurrentfinancialassets": 68500000,
    "fixedinterest": 0.04125,
    "financialassetsfromgovernmentgrantsamount": 700000,
    "eligiblecostsincurred": 700000,
    "capitalordinarysharesissued": 44703763,
    "commonshares": 50000000,
    "assetssoldunderagreementtorepurchasecarryingamount": 35200000,
    "ordinarysharepurchase": 110000000,
    "preferredunitissued": 110000000,
    "nominalorprincipalamountoffinancialinstrumentondiscontinuationofmeasurementatfairvaluethroughprofitorlossbecausecreditderivativeisusedtomanagecreditrisk": 0.12,
    "companyissuedcapital": 1,
    "expectedreimbursementotherprovisions": 60000,
    "commonsharesinexcessofnominalvalue": 0.12,
    "variablesheldconstant": 0.1,
    "gainslossesonexchangedifferencesontranslationbeforetax": 1000000,
    "exchangeratefluctuations": 1.1733,
    "materialimpact": 1.0666,
    "maximumexposuretocreditrisk": 84000000,
    "noncurrentrestrictedcashandcashequivalents": 16300000,
    "otherfinancialassets": 67700000,
    "cashonhand": 17300000,
    "convertedwiththeexchangerate": 0.010666,
    "numberofoperatingsegment": 1,
    "otherrevenue": 100000,
    "interestincomeonimpairedfinancialassetsaccrued": 100000,
    "entityregistrantname": "InflaRxN.V.",
    "tradingsymbol": "IFRX",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "December 31",
    "entitycommonstocksharesoutstanding": 44703763,
    "amendmentflag": "false",
    "entitycentralindexkey": 1708688,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "true",
    "icfrauditorattestationflag": "true",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "001-38283",
    "entityincorporationstatecountrycode": "Netherlands",
    "entityaddressaddressline1": "WinzerlaerStr. 2",
    "entityaddressaddressline2": 7745,
    "entityaddresscityortown": "Jena",
    "entityaddresscountry": "Germany",
    "contactpersonnelname": "Dr.Thomas Taapken",
    "cityareacode": 49,
    "localphonenumber": "(3641) 508 180",
    "security12btitle": "Common Shares, nominal value €0.12 per share",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorfirmid": 1251,
    "auditorname": "Ernst & YoungGmbH Wirtschaftsprüfungsgesellschaft",
    "auditorlocation": "Munich, Germany"
  },
  {
    "date": "2021-12-31",
    "symbol": "IFRX",
    "period": "FY",
    "entityregistrantname": "InflaRx N.V.",
    "entitycentralindexkey": 1708688,
    "documenttype": "20-F",
    "amendmentflag": "false",
    "entityvoluntaryfilers": "No",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityshellcompany": "false",
    "entityemerginggrowthcompany": "true",
    "entitycurrentreportingstatus": "Yes",
    "documentperiodenddate": "December 31, 2021",
    "entityfilercategory": "Accelerated Filer",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2022,
    "entityextransitionperiod": "false",
    "entitycommonstocksharesoutstanding": "null",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38283",
    "entityincorporationstatecountrycode": "Netherlands",
    "entityaddressaddressline1": "Fraunhoferstr. 22, 82152",
    "entityaddressaddressline2": 7745,
    "entityaddresscityortown": "Planegg-Martinsried",
    "entityaddresscountry": "Germany",
    "icfrauditorattestationflag": "false",
    "auditorname": "Ernst & Young GmbH Wirtschaftsprüfungsgesellschaft",
    "auditorlocation": "Munich, Germany",
    "auditorfirmid": 1251,
    "security12btitle": "Common Shares, nominal value €0.12 per share",
    "tradingsymbol": "IFRX",
    "securityexchangename": "The NASDAQ Stock Market LLC",
    "entityinteractivedatacurrent": "Yes",
    "documentshellcompanyreport": "false",
    "documentregistrationstatement": "false",
    "contactpersonnelname": "Dr. Thomas Taapken",
    "documentaccountingstandard": "U.S. GAAP",
    "cityareacode": 49,
    "localphonenumber": "89 4141 897 800",
    "researchanddevelopmentexpense": 434331,
    "sellinggeneralandadministrativeexpense": 979884,
    "operatingexpense": "null",
    "otherincome": 54221,
    "otherexpensebynature": 6381,
    "operatingresult": "-null",
    "financeincome": 109391,
    "financecosts": -14055,
    "gainslossesonexchangedifferencesontranslationbeforetax": "-null",
    "otherfinanceincomecost": -44000,
    "profitloss": "-null",
    "weightedaverageshares": "null",
    "basicanddilutedearningslosspershare": -1.1,
    "profitlossforperiod": "-null",
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": "null",
    "comprehensiveincome": "null",
    "propertyplantandequipment": 274373,
    "rightofuseassets": 49116,
    "intangibleassetsotherthangoodwill": 235216,
    "othernoncurrentassets": 336566,
    "noncurrentfinancialassets": "null",
    "noncurrentassets": 200000,
    "othercurrentassets": "null",
    "currenttaxassets": "null",
    "currentfinancialassets": "null",
    "cashandcashequivalents": "null",
    "currentassets": "null",
    "assets": "null",
    "issuedcapital": "null",
    "sharepremium": "null",
    "otherreserves": "null",
    "retainedearnings": "-null",
    "othercomponentsofequity": "null",
    "equity": "null",
    "noncurrentleaseliabilities": "null",
    "othernoncurrentliabilities": 35019,
    "noncurrentliabilities": "null",
    "tradeandothercurrentpayables": "null",
    "liabilitiesfromgovernmentgrantsreceived": "null",
    "currentleaseliabilities": 366171,
    "currentprovisionsforemployeebenefits": "null",
    "othercurrentliabilities": 138206,
    "currentliabilities": "null",
    "liabilities": "null",
    "equityandliabilities": "null",
    "numberofsharesoutstanding": "null",
    "gainslossesonexchangedifferencesontranslationnetoftax": "null",
    "increasedecreasethroughsharebasedpaymenttransactions": "null",
    "increasedecreasethroughexerciseofoptionsshares": 365326,
    "increasedecreasethroughexerciseofoptions": "null",
    "issuanceofcommonsharesshares": "null",
    "issuanceofcommonsharesamount": "null",
    "shareissuerelatedcost": "-null",
    "adjustmentsfordepreciationexpense": 669434,
    "adjustmentsforfinanceincomecost": "-null",
    "expensefromsharebasedpaymenttransactionswithemployees": "null",
    "adjustmentsforunrealisedforeignexchangelossesgains": 111606,
    "adjustmentsfordecreaseincreaseinotherassets": "-null",
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": -3290,
    "adjustmentsforincreasedecreaseinotherliabilities": 19863,
    "adjustmentsforincreasedecreaseinliabilitiesfromgovernmentgrantreceived": "null",
    "adjustmentsforincreasedecreaseintradeaccountpayable": 316112,
    "interestreceivedclassifiedasoperatingactivities": "null",
    "interestpaidclassifiedasoperatingactivities": -23633,
    "cashflowsfromusedinoperatingactivities": "-null",
    "purchaseofintangibleassetsclassifiedasinvestingactivities": -37778,
    "adjustmentsfordecreaseincreaseinothercurrentassets": "-null",
    "proceedsfromdisposalormaturityofavailableforsalefinancialassets": "null",
    "cashflowsfromusedininvestingactivities": "-null",
    "proceedsfrommissuanceofcommonstock": "null",
    "proceedsfromexerciseofoptions": "null",
    "repaymentsofborrowingsclassifiedasfinancingactivities": -360644,
    "cashflowsfromusedinfinancingactivities": "null",
    "increasedecreaseincashandcashequivalents": "-null",
    "effectofexchangeratechangesoncashandcashequivalents": "null",
    "countryofincorporation": "U.S",
    "descriptionoffunctionalcurrency": "USD",
    "proportionofownershipinterestinsubsidiary": 1,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Subsidiary for basic research",
    "rightofuseassetsusefullife": "range between12 and 65 months",
    "descriptionofexpectedvolatilityshareoptionsgranted": 0.013500000000000002,
    "prepayments": "null",
    "treatmentofsevereamount": 43700000,
    "descriptionofreimburesement": "Expenses incurred from October 1, 2021 until June 30, 2023 are eligible for 80% reimbursement throughout the funding period, if certain funding conditions are met",
    "paymentreceived": 8300000.000000001,
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": 13,
    "employeebenefitsexpense": "null",
    "financeincomecost": 84622,
    "numberofoutstandingshareoptions": "null",
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": -36400,
    "numberofotherequityinstrumentsexercisableinsharebasedpaymentarrangement": "null",
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.01,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentarrangement2019": 2.83,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentarrangement2019": 0.01,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": "null",
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": -159106,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentarrangement2019": 3.82,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentarrangement2019": 4.02,
    "shareoptionsoutstanding": "null",
    "fairvalueperoptionusd": 2.66,
    "foreignexchangerateasofgrantdate": 0.8458,
    "fairvalueperoptioneur": 2.25,
    "sharepriceatgrantdateusd": 2.99,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": 5.49,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0101,
    "exercisepriceofoutstandingshareoptions2019": 0.01,
    "numberofstockoptionsawarded": 75000,
    "numberofstockoptionsgranted": "null",
    "increaseinmaximumannualnumberofsharespercentage": 0.04,
    "adjustedweightedaverageshares": "null",
    "decreaseininterestincome": 778,
    "increasedecreaseinallowanceaccountforcreditlossesoffinancialassets": 44000,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions": 6.18,
    "weightedaveragefairvalueeoptionsgrantedduringtheyear": 3.37,
    "weightedaveragefairvalueeoptionsgrantedduringtheyearusd": 3.99,
    "exercisepricerangeminimumeuro": 2.01,
    "exercisepricerangemaximumeuro": 20.09,
    "exercisepricerangemaximumdollar": 22.75,
    "exercisepricerangeminimumdollar": 2.28,
    "averagevolatilityrate": 1.1500000000000001,
    "numberofstockoptionsforfeited": 36400,
    "conversionrate": 1.0193,
    "averagerate": 0.8149,
    "maximumnumberofcommonsharesavailableforgrant": "null",
    "propertyplantequipmentbalance": -993238,
    "adjustmentsfordepreciationandamortisationexpense": -181900,
    "propertyplantandequipmentexchangedifferences": -20060,
    "propertyplantequipmentadditions": 36938,
    "rightofuseassetsbalance": "-null",
    "depreciationrightofuseassets": 371551,
    "rightofuseassetsexchangedifferences": -7952,
    "additionstorightofuseassets": "null",
    "intangibleassetsbalance": -485726,
    "adjustmentsforamortisationexpense": -115982,
    "intangibleassetsexchangedifferences": -334,
    "intangibleassetsadditions": 840,
    "leaseliabilities": "null",
    "additionstoleaseliabilities": "null",
    "derecognitionofleaseliabilities": -20555,
    "repaymentsofleaseliabilities": -340088,
    "shorttermliabilityforaccruedinterestexpense": 1136,
    "leaseliabilityforeignexchangedifference": 7882,
    "interestexpenseonleaseliabilities": 14055,
    "rentalexpense": 6261,
    "leaseoflowvalueassets": 6261,
    "totalamountsrecognizedinprofitorloss": 391867,
    "othernoncurrentnonfinancialassets": 336566,
    "othercurrentnonfinancialassets": "null",
    "othernonfinancialassets": "null",
    "profitlossbeforetax": "-null",
    "applicabletaxrate": 0.28500000000000003,
    "taxexpenseincomeatapplicabletaxrate": "null",
    "taxlossesforwhichnodeferredincometaxassetwasrecognized": "-null",
    "financialassetscurrent": "null",
    "tradeandotherpayables": 964486,
    "shorttermdepositsclassifiedascashequivalents": "null",
    "balanceswithbanks": "null",
    "liabilitiesreceivedfromgovernmentgrants": 8300000.000000001,
    "cashoutflowforleases": 379868,
    "corporateincometaxrate": 0.15,
    "solidaritysurchargerate": 0.008,
    "tradetaxesrate": 0.128,
    "averageeffectivetaxrate": 0.28600000000000003,
    "annarbormichiganusaaveragetotaltaxrate": 0.27,
    "usfederaltaxrate": 0.21,
    "usstatetaxrate": 0.06,
    "incometaxreceivablecurrent": 812689,
    "unusedtaxlossescarriedforward": "null",
    "taxlossesusedtooffsetfuturetaxableincome": "null",
    "taxlosscarryforwards": 186900000,
    "fairvaluefinancialassets": 84376000,
    "numberofsharesissued": "null",
    "parvaluepershare": 0.12,
    "descriptionofcommonsharessalesagreement": "the Company filed a Form F-3 (Registration Statement) with the United States Securities and Exchange Commission (SEC) with respect to the offer and sale of securities of the Company. The Company also filed with the SEC a prospectus supplement (Prospectus Supplement) relating to an at-the-market program providing for the sale of up to $50,000,000 of its common shares over time pursuant a Sales Agreement with SVB Leerink LLC",
    "remainingvalueauthorizedforsaleunderthesalesagreement": 35200000,
    "numberofsharesauthorised": "null",
    "ongoingcoststoreimburseexpenses": 60000,
    "fixedinterestrange": 7.875,
    "taxlosscarryforward": 11510188,
    "amortisationintangibleassetsotherthangoodwill": 105790,
    "riskexposure": "R&D and GA cost, equity, trade and other payables",
    "riskmeasurement": "Rolling cash flow forecast",
    "riskmanagement": "Availability of funds through financing rounds or public offerings",
    "currentfinancialassetssubsidiary": "null",
    "cashandcashequivalentssubsidiary": "null",
    "assetsexposedtorisk": "null",
    "increasedecreasethroughnetexchangedifferencesotherprovisions": "null",
    "cash": "null",
    "cashandbankbalancesatcentralbanks": "null",
    "marketablesecuritiestotal": "null",
    "othernoncurrentfinancialassets": 272581,
    "othercurrentfinancialassets": 387449,
    "fundsavailable": "null",
    "creditexposure": 110600000,
    "carryingamountofcashandcashequivalents": 26200000,
    "financialassets": 84400000,
    "cashreceivedasgrantfromgermanfederalgovernment": 8300000.000000001,
    "contractualminimumleaseobligations": "null",
    "effectofdiscounting": 46729,
    "grossleaseliabilities": "null",
    "totalleaseobligations": "null",
    "lowvaluelease": 17484,
    "capitalizedlease": "null",
    "eurotousdexchangerate": 1.1326,
    "keymanagementpersonnelcompensation": "null",
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 271248,
    "keymanagementpersonnelcompensationsharebasedpayment": 488937,
    "shorttermemployeebenefitsaccruals": 225146
  },
  {
    "date": "2020-12-31",
    "symbol": "IFRX",
    "period": "FY",
    "entityregistrantname": "InflaRx N.V.",
    "entitycentralindexkey": 1708688,
    "documenttype": "20-F",
    "documentperiodenddate": "2020-12-31",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "P7",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entitycommonstocksharesoutstanding": 28228415,
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2020,
    "researchanddevelopmentexpense": 4480890,
    "sellinggeneralandadministrativeexpense": 283128,
    "operatingexpense": 34151343,
    "otherincome": 221748,
    "otherexpensebynature": 13209,
    "operatingresult": -33942804,
    "financeincome": 887702,
    "financecosts": 7311,
    "gainslossesonexchangedifferencesontranslationbeforetax": -4433435,
    "otherfinanceincomecost": -126000,
    "profitloss": -33983614,
    "adjustedweightedaverageshares": 27064902,
    "basicanddilutedearningslosspershare": -1.26,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": -5954019,
    "comprehensiveincome": -5954019,
    "propertyplantandequipment": 408263,
    "rightofuseassets": 546694,
    "intangibleassetsotherthangoodwill": 350184,
    "othernoncurrentnonfinancialassets": 353522,
    "othernoncurrentfinancialassets": 272268,
    "noncurrentassets": 219000,
    "othercurrentnonfinancialassets": 3734700,
    "currenttaxassets": 1419490,
    "currentfinancialassets": 55162033,
    "cashandcashequivalents": 25968681,
    "currentassets": 86284904,
    "assets": 88215834,
    "issuedcapital": 3387410,
    "sharepremium": 220289876,
    "otherreserves": 26259004,
    "retainedearnings": -168345620,
    "othercomponentsofequity": -3726791,
    "equity": -3726791,
    "noncurrentleaseliabilities": 220525,
    "othernoncurrentnonfinancialliabilities": 33323,
    "noncurrentliabilities": 253847,
    "tradeandothercurrentpayables": 5250654,
    "currentleaseliabilities": 338516,
    "currentprovisionsforemployeebenefits": 1368731,
    "othercurrentnonfinancialliabilities": 117727,
    "provisions": 15000,
    "currentliabilities": 10098107,
    "liabilities": 10351954,
    "equityandliabilities": 88215834,
    "numberofsharesoutstanding": 28228415,
    "gainslossesonexchangedifferencesontranslationnetoftax": -5954019,
    "issueofsharecapitalshares": 1958186,
    "issueofsharecapital": 9535961,
    "shareissuerelatedcost": -729840,
    "increasedecreasethroughsharebasedpaymenttransactions": 1116791,
    "increasedecreasethroughexerciseofoptionsshares": 164974,
    "increasedecreasethroughexerciseofoptions": 477149,
    "profitlossbeforetax": -33983614,
    "adjustmentsfordepreciationexpense": 712713,
    "adjustmentsforfinanceincomecost": -40810,
    "expensefromsharebasedpaymenttransactionswithemployees": 1116791,
    "adjustmentsforunrealisedforeignexchangelossesgains": -247322,
    "otheradjustmentsfornoncashitems": 3436,
    "adjustmentsfordecreaseincreaseinotherassets": -1554611,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 355545,
    "adjustmentsforincreasedecreaseinotherliabilities": 8960,
    "adjustmentsforincreasedecreaseintradeaccountpayable": -4155529,
    "interestreceivedclassifiedasoperatingactivities": 1201547,
    "interestpaidclassifiedasoperatingactivities": 26387,
    "cashflowsfromusedinoperatingactivities": -36527661,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 94189,
    "purchaseofcurrentfinancialassets": 101600176,
    "proceedsfromdisposalormaturityofavailableforsalefinancialassets": 123056347,
    "cashflowsfromusedininvestingactivities": 21361982,
    "issuedsharecapital": -9770944,
    "proceedsfromexerciseofoptions": 496946,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 366156,
    "cashflowsfromusedinfinancingactivities": 9171893,
    "increasedecreaseincashandcashequivalents": -5993786,
    "effectofexchangeratechangesoncashandcashequivalents": -1168813,
    "countryofincorporation": "Germany",
    "descriptionoffunctionalcurrency": "EUR",
    "proportionofownershipinterestinsubsidiary": 1,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Principal operating subsidiary, biopharmaceutical company",
    "descriptionofusefullifepropertyplantandequipment": "1 to 5 years",
    "prepayments": 2340643,
    "employeebenefitsexpense": 1116791,
    "financeincomecost": 861702,
    "numberofoutstandingshareoptions": 2146478,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 246188,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 78342,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 202473,
    "numberofotherequityinstrumentsexercisableinsharebasedpaymentarrangement": 1863790,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentsarrangement": 2.93,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentsarrangement": 4.23,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentsarrangement": 2.94,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentsarrangement": 3.17,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentsarrangement": 2.82,
    "shareoptionsoutstanding": 150000,
    "fairvalueperoptionusd": 3.69,
    "foreignexchangerateasofgrantdate": 0.85,
    "fairvalueperoptioneur": 3.14,
    "sharepriceatgrantdateusd": 4.83,
    "descriptionofexpectedvolatilityshareoptionsgranted": 1.35,
    "descriptionofoptionlifeshareoptionsgranted": 5,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0036,
    "propertyplantequipmentbalance": -791277,
    "adjustmentsfordepreciationandamortisationexpense": 212733,
    "propertyplantequipmentadditions": 66114,
    "propertyplantandequipmentdisposal": -1793,
    "propertyplantandequipmentexchangedifferences": 16764,
    "rightofuseassetsbalance": -47361,
    "depreciationrightofuseassets": 362137,
    "additionstorightofuseassets": 101993,
    "disposalsofrightofuseassets": -7880,
    "rightofuseassetsexchangedifferences": -6277,
    "intangibleassetsbalance": -369410,
    "adjustmentsforamortisationexpense": 129963,
    "intangibleassetsadditions": 28075,
    "intangibleassetsreclassifications": -8190,
    "intangibleassetsexchangedifferences": 234,
    "leaseliabilities": 559041,
    "additionstoleaseliabilities": 101993,
    "derecognitionofleaseliabilities": -20555,
    "repaymentsofleaseliabilities": -366156,
    "shorttermliabilityforaccruedinterestexpense": -388,
    "leaseliabilityforeignexchangedifference": -1802,
    "interestexpenseonleaseliabilities": 7311,
    "rentalexpense": 6275,
    "shorttermleases": 937,
    "leaseoflowvalueassets": 5338,
    "totalamountsrecognizedinprofitorloss": 375723,
    "othernonfinancialassets": 4088221,
    "applicabletaxrate": 0.287,
    "taxexpenseincomeatapplicabletaxrate": 9761910,
    "taxlossesforwhichnodeferredincometaxassetwasrecognized": -9761910,
    "noncurrentfinancialassets": 272268,
    "financialassetscurrent": 47138738,
    "tradeandotherpayables": 1266228,
    "shorttermdepositsclassifiedascashequivalents": 1800000,
    "balanceswithbanks": 1189126,
    "amortisationintangibleassetsotherthangoodwill": 102026,
    "cashoutflowforleases": 374698,
    "taxlosscarryforward": 148900000,
    "incometaxreceivablecurrent": 1026494,
    "riskexposure": "R&D and G&A cost, equity, trade and other payables",
    "riskmeasurement": "Rolling cash flow forecast",
    "riskmanagement": "Availability of funds through financing rounds or public offerings",
    "currentfinancialassetssubsidiary": 8333240,
    "cashandcashequivalentssubsidiary": 22530687,
    "assetsexposedtorisk": 30863927,
    "closingforeignexchangerate": 1.05,
    "increasedecreasethroughnetexchangedifferencesotherprovisions": 3429325,
    "cash": 34293252,
    "cashandbankbalancesatcentralbanks": 1551914,
    "marketablesecuritiestotal": 54752700,
    "othercurrentfinancialassets": 409333,
    "fundsavailable": 81402982,
    "creditexposure": 81400000,
    "contractualminimumleaseobligations": 231715,
    "effectofdiscounting": 11190,
    "grossleaseliabilities": 220525,
    "totalleaseobligations": 249199,
    "lowvaluelease": 17484,
    "capitalizedlease": 231715,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 283127,
    "keymanagementpersonnelcompensationsharebasedpayment": 69938,
    "keymanagementpersonnelcompensation": 353065
  },
  {
    "date": "2019-12-31",
    "symbol": "IFRX",
    "period": "FY",
    "entityregistrantname": "InflaRx N.V.",
    "entitycentralindexkey": 1708688,
    "documenttype": "20-F",
    "documentperiodenddate": "2019-12-31",
    "amendmentflag": "false",
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Accelerated Filer",
    "entityemerginggrowthcompany": "true",
    "entityextransitionperiod": "false",
    "entityshellcompany": "false",
    "entityinteractivedatacurrent": "Yes",
    "entityincorporationstatecountrycode": "P7",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entitycommonstocksharesoutstanding": 26105255,
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2019,
    "researchanddevelopmentexpense": 2580983,
    "sellinggeneralandadministrativeexpense": 4251227,
    "operatingexpense": 57083184,
    "otherincome": 400253,
    "otherexpensebynature": 85242,
    "operatingresult": -56768173,
    "financeincome": 2840676,
    "financecosts": 22265,
    "netfinancialresult": 3513355,
    "profitloss": -53254817,
    "adjustedweightedaverageshares": 26004519,
    "basicanddilutedearningslosspershare": -2.05,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": 2177033,
    "comprehensiveincome": 2177033,
    "propertyplantandequipment": 1413297,
    "intangibleassetsotherthangoodwill": 452400,
    "othernoncurrentnonfinancialassets": 452217,
    "othernoncurrentfinancialassets": 272614,
    "noncurrentassets": 2590528,
    "othercurrentnonfinancialassets": 3500884,
    "currentfinancialassets": 82353867,
    "cashandcashequivalents": 33131280,
    "currentassets": 118986031,
    "assets": 121576558,
    "issuedcapital": 3132631,
    "sharepremium": 211006606,
    "otherreserves": 25142213,
    "retainedearnings": -134362006,
    "othercomponentsofequity": 2227228,
    "equity": 2227228,
    "noncurrentleaseliabilities": 330745,
    "othernoncurrentnonfinancialliabilities": 39013,
    "noncurrentliabilities": 369758,
    "currentleaseliabilities": 515203,
    "currentprovisionsforemployeebenefits": 975629,
    "currentpayablesonsocialsecurityandtaxesotherthanincometax": 105634,
    "tradeandothercurrentpayables": 12413662,
    "provisions": 50000,
    "currentliabilities": 14060128,
    "liabilities": 14429886,
    "equityandliabilities": 121576558,
    "numberofsharesoutstanding": 26105255,
    "gainslossesonexchangedifferencesontranslationnetoftax": 2177033,
    "increasedecreasethroughsharebasedpaymenttransactions": 6832210,
    "increasedecreasethroughexerciseofoptionsshares": 140876,
    "increasedecreasethroughexerciseofoptions": -15229,
    "totalincreasedecreaseshares": 140876,
    "totalincreasedecreaseamount": -15229,
    "transactionswithownersofcompanyshares": 140876,
    "transactionswithownersofcompany": -15229,
    "profitlossbeforetax": -2177602,
    "adjustmentsfordepreciationexpense": 663166,
    "adjustmentsforfinanceincomecost": 3513355,
    "expensefromsharebasedpaymenttransactionswithemployees": 4600000,
    "otheradjustmentsfornoncashitems": -307849,
    "adjustmentsfordecreaseincreaseinothernonfinancialassets": -2364399,
    "adjustmentsforincreasedecreaseinemployeebenefitliabilities": 235500,
    "adjustmentsforincreasedecreaseinsocialsecuritiesandothertaxliabilities": -209948,
    "adjustmentsforincreasedecreaseintradeaccountpayable": 5734795,
    "interestreceivedclassifiedasoperatingactivities": 3001109,
    "interestpaidclassifiedasoperatingactivities": 20903,
    "cashflowsfromusedinoperatingactivities": -43204492,
    "purchaseofintangibleassetsclassifiedasinvestingactivities": 594889,
    "purchaseofinvestmentsinnoncurrentfinancialassets": 75543,
    "proceedsfromdisposalofcurrentfinancialassetsorrepaymentofmaturingsecurities": 103559395,
    "purchaseofcurrentnoncurrentfinancialassets": 82547409,
    "cashflowsfromusedininvestingactivities": 20341554,
    "proceedsfromexerciseofoptions": 1676,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 296020,
    "cashflowsfromusedinfinancingactivities": -294344,
    "effectofexchangeratechangesoncashandcashequivalents": 902321,
    "increasedecreaseincashandcashequivalents": -22254960,
    "employeebenefitsexpense": 6832210,
    "financeincomecost": 3513355,
    "taxlosscarryforward": 3816023,
    "applicabletaxrate": 0.27,
    "taxexpenseincomeatapplicabletaxrate": 587953,
    "taxlossesforwhichnodeferredincometaxassetwasrecognized": -587953,
    "propertyplantequipmentbalance": -863058,
    "adjustmentsfordepreciationandamortisationexpense": 556808,
    "propertyplantequipmentadditions": 1681412,
    "propertyplantandequipmentdisposal": 64243,
    "propertyplantandequipmentreclassification": -54408,
    "propertyplantandequipmentexchangedifferences": 18,
    "propertyplantandequipmentbookvalue": 590600,
    "intangibleassetsbalance": -239681,
    "adjustmentsforamortisationexpense": 106358,
    "intangibleassetsadditions": 251493,
    "intangibleassetsreclassifications": -353155,
    "intangibleassetsexchangedifferences": 14,
    "intangibleassetsnetbookvalue": 8190,
    "leaseliabilities": 14227,
    "additionstorightofuseassets": 636754,
    "depreciationrightofuseassets": 20831,
    "decreasethroughderecognitionfinancialassets": 266057,
    "interestexpense": 12765,
    "paymentsincludinginterestandforeignexchangedifference": -281535,
    "contractualminimumleaseobligations": 500062,
    "effectofdiscounting": 3185,
    "grossleaseliabilities": 496877,
    "totalleaseobligations": 532845,
    "lowvaluelease": 12779,
    "shorttermlease": 20005,
    "capitalizedlease": 500062,
    "interestexpenseonleaseliabilities": 12765,
    "rentalexpense": 70451,
    "shorttermleases": 65348,
    "leaseoflowvalueassets": 5103,
    "totalamountsrecognizedinprofitorloss": 349173,
    "othernonfinancialassets": 698891,
    "noncurrentfinancialassets": 272614,
    "tradeandotherpayables": 12413662,
    "usdtermdeposits": 27803153,
    "shorttermdepositsclassifiedascashequivalents": 27803153,
    "moneyheldineuro": 1211478,
    "moneyheldinu.s.dollars": 4116649,
    "moneyheld": 5328127,
    "riskexposure": "R&D and G&A cost and trade payables",
    "riskmeasurement": "Rolling cash flow forecast",
    "riskmanagement": "Availability of funds through financing rounds or public offerings",
    "currentfinancialassetssubsidiary": 32947491,
    "cashandcashequivalentssubsidiary": 4123532,
    "assetsexposedtorisk": 37071023,
    "closingforeignexchangerate": 1.2357,
    "increasedecreasethroughnetexchangedifferencesotherprovisions": -3370093,
    "cash": 33700930,
    "cashandbankbalancesatcentralbanks": 5328127,
    "marketablesecuritiestotal": 81895377,
    "othercurrentfinancialassets": 458491,
    "fundsavailable": 115757762,
    "creditexposure": 115800000,
    "financialassets": 82600000,
    "commitmentsforminimumleasepaymentsinrelationtononcancellableoperatingleases": 532845,
    "commitmentsforminimumpaymentsinrelationtononcancellableoperatingcontractsorservices": 13844857,
    "countryofincorporation": "Germany",
    "descriptionoffunctionalcurrency": "EUR",
    "proportionofownershipinterestinsubsidiary": 1,
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Principal operating subsidiary, biopharmaceutical company",
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 269031,
    "keymanagementpersonnelcompensationsharebasedpayment": 710611,
    "keymanagementpersonnelcompensation": 979642,
    "numberofoutstandingshareoptions": 2181105,
    "numberofshareoptionsexercisedinsharebasedpaymentarrangement": 140876,
    "numberofshareoptionsgrantedinsharebasedpaymentarrangement": 242450,
    "numberofshareoptionsforfeitedinsharebasedpaymentarrangement": 112354,
    "numberofotherequityinstrumentsexercisableinsharebasedpaymentarrangement": 1319548,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentsarrangement": 3.06,
    "weightedaverageexercisepriceofshareoptionsexercisedinsharebasedpaymentsarrangement": 0.01,
    "weightedaverageexercisepriceofshareoptionsgrantedinsharebasedpaymentsarrangement": 2.91,
    "weightedaverageexercisepriceofshareoptionsforfeitedinsharebasedpaymentsarrangement": 5.51,
    "weightedaverageexercisepriceofshareoptionsexercisableinsharebasedpaymentsarrangement": 3.13,
    "shareoptionsoutstanding": 100000,
    "fairvalueperoptionusd": 1.08,
    "foreignexchangerateasofgrantdate": 0.9,
    "fairvalueperoptioneur": 0.96,
    "sharepriceatgrantdateusd": 3.57,
    "descriptionofexpectedvolatilityshareoptionsgranted": 1.35,
    "descriptionofoptionlifeshareoptionsgranted": 4.6,
    "descriptionofriskfreeinterestrateshareoptionsgranted": 0.0179,
    "sharebasedcompensationexpense2016plan": 4000000,
    "sharebasedcompensationexpense2017incentiveplan": 600000,
    "sharebasedcompensation2016planrepriced": 500000,
    "sharebasedcompensation2017incentiveplanrepriced": 1100000
  }
]